Articles From This Issue
COVER FOCUS
Five Pointers on Malignant Glaucoma
By Jeffrey R. SooHoo, MD; Leonard K. Seibold, MD; and Malik Y. Kahook, MD
Prompt recognition and treatment are essential to reduce the risk of vision loss.
COVER FOCUS
Five Pointers on Bleb Leaks
By Georges M. Durr, MD, FRCSC
A look at emerging technologies targeting the suprachoroidal space.
COVER FOCUS
Five Pointers on Glaucoma Drainage Device Exposure
By Enny Oyeniran, MD; and Victoria Addis, MD
Fundamental tips that may help prevent vision-threating endophthalmitis.
Supplements and CME
Sustained-Release Devices for the Treatment of Chronic Eye Dseases
Supported through an educational grant by Allergan and EyePoint Pharmaceuticals.
Current and Future Glaucoma Management: An Update on Existing Options and the Therapeutic Pipeline
This activity is supported by an unrestricted educational grant from Bausch + Lomb.
NEWS
EyeGate Pharma Submits Investigational Device Exemption Amendment for Second Pil…
EyeGate Pharmaceuticals announced that it has submitted an amended Investigational Device Exemption …
Icon Bioscience Receives FDA Approval for Dexycu Drug Therapy for Treating Infla…
Icon Bioscience announced that the FDA has approved the company's new drug application for Dexyc…
EyeGate Announces Topline Results for Phase 2b Trial of EGP-437 in Cataract Surg…
EyeGate Pharmaceuticals announced topline results from a phase 2b study of EGP-437 combination produ…
Patients Are Going Blind Due to 6-Month Waiting Lists for Cataract Surgery
Patients face going blind while waiting for cataract surgery after new figures showed waiting times …
Featured Content
